ECOR - エレクトロコア （electroCore Inc.） エレクトロコアECORのチャート
ECORの企業情報
| symbol | ECOR |
|---|---|
| 会社名 | ElectroCore Inc （エレクトロコア） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ElectroCore Inc. formerly ElectroCore LLC is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology psychiatry gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache) and the associated chronic co-morbidities of gastric motility psychiatric sleep and pain disorders. エレクトロコアは米国のバイオエレクトロニクス企業。主に神経系疾患やリウマチなどの治療のために、非侵襲的な迷走神経刺激法の開発に従事する。同社は成人の偏頭痛およびエピソ―ドクラスタ―頭痛の急性疼痛の治療のために、処方箋のみの迷走神経刺激法のgammaCore(ガンマコア)を開発する。本社所在地はニュ―ジャ―ジ―州ベ―スキング・リッジ。 electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache. |
| 本社所在地 | 150 Allen Road Suite 201 Basking Ridge NJ 07920 USA |
| 代表者氏名 | J.P. Errico J.P.エリコ |
| 代表者役職名 | Chairman of the Board Co-Founder Principal Investor and Chief Science_Strategy Officer |
| 電話番号 | +1 973-290-0097 |
| 設立年月日 | 38596 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | 64人 |
| url | www.electrocore.com |
| nasdaq_url | https://www.nasdaq.com/symbol/ecor |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -38.75351 |
| 終値（lastsale） | 13.28 |
| 時価総額（marketcap） | 391096451.52 |
| 時価総額 | 時価総額（百万ドル） 386.08990 |
| 売上高 | 売上高（百万ドル） 0.99239 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 290.26335 |
| 当期純利益 | 当期純利益（百万ドル） -45.14816 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 electroCore Inc. revenues increased 62% to $474K. Net loss increased 52% to $27.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative increase from $7.9M to $18.8M (expense) Research and development increase of 48% to $6.7M (expense). |
ECORのテクニカル分析
ECORのニュース
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC. 2021/08/24 12:00:00 Intrado Digital Media
ROCKAWAY, NJ, Aug. 24, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a reseller agreement with Red One Medical Devices, LLC. (Red One). The partnership will further expand availability of electroCores gammaCore platform in the federal marketplace.
Neurostimulation Devices Market to Witness Outstanding Growth, Key Players -Boston scientific corporation ElectroCore Inc. 2021/08/24 10:45:39 OpenPR
The market research report from DECISIVE MARKETS INSIGHTS considers a few market-related principles to help readers make smarter, better, and competitive strategic decisions in the broader market industry. It contains critical market statistics and information derived primarily from primary and
Have an attention on: Predictive Oncology Inc. (NASDAQ:POAI), electroCore, Inc. (NASDAQ:ECOR) 2021/08/22 21:37:29 Stock Equity
Predictive Oncology Inc. (POAI) with the stream of 2.00% also noticed, India electroCore, Inc. (ECOR) encountered a rapid change of 0.04% in the last hour of Fridays trading session. Predictive The post Have an attention on: Predictive Oncology Inc. (NASDAQ:POAI), electroCore, Inc. (NASDAQ:ECOR) appeared first on Stocks Equity .
Migraine Treatment Market is Expected to Grow at an Impressive CAGR by 2028 || Abbott, Cefaly Technology, Aegis Theraputics, LLC, Electrocore, Inc, Aerial BioPharma LLC, ALDER BIOPHARMACEUTICALS, INC 2021/08/19 12:59:23 OpenPR
The Migraine Treatment Market research report delivered by Data Bridge Market research gives the market division dependent on type, market size, Product dispatches and applications. It distinguishes the worldwide reception of the items as one of the development factors, driven
This Stock is in a moonbeam: electroCore, Inc. (NASDAQ:ECOR), Coty Inc. (NYSE:COTY) 2021/07/18 22:58:09 Stock Equity
electroCore, Inc. (ECOR) with the stream of -2.86% also noticed, India Coty Inc. (COTY) encountered a rapid change of -1.63% in the last hour of trading session. electroCore, Inc. (NASDAQ:ECOR) The post This Stock is in a moonbeam: electroCore, Inc. (NASDAQ:ECOR), Coty Inc. (NYSE:COTY) appeared first on Stocks Equity .
Most Recent Figure Make This Stock Even More Attractive: Li Auto Inc. (NASDAQ:LI), electroCore, Inc. (NASDAQ:ECOR) 2021/07/14 21:01:54 Stock Equity
Li Auto Inc. (LI) with the stream of -6.98% also noticed, India electroCore, Inc. (ECOR) encountered a rapid change of -3.61% in the last hour of Wednesdays trading session. Li The post Most Recent Figure Make This Stock Even More Attractive: Li Auto Inc. (NASDAQ:LI), electroCore, Inc. (NASDAQ:ECOR) appeared first on Stocks Equity .
Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore? 2021/07/13 12:30:00 Benzinga
NEW YORK , July 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CETX, TPST, XELA, OGI, and ECOR.
electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance 2021/07/13 12:00:00 Intrado Digital Media
ROCKAWAY, NJ, July 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the second quarter of 2021.
Most Recent Figure Make This Stock Even More Attractive: Li Auto Inc. (NASDAQ:LI), electroCore, Inc. (NASDAQ:ECOR) 2021/07/14 21:01:54 Stock Equity
Li Auto Inc. (LI) with the stream of -6.98% also noticed, India electroCore, Inc. (ECOR) encountered a rapid change of -3.61% in the last hour of Wednesdays trading session. Li The post Most Recent Figure Make This Stock Even More Attractive: Li Auto Inc. (NASDAQ:LI), electroCore, Inc. (NASDAQ:ECOR) appeared first on Stocks Equity .
Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore? 2021/07/13 12:30:00 Benzinga
NEW YORK , July 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CETX, TPST, XELA, OGI, and ECOR.
electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance 2021/07/13 12:00:00 Intrado Digital Media
ROCKAWAY, NJ, July 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the second quarter of 2021.
Hot Mover of the Day: Inpixon (NASDAQ:INPX), electroCore, Inc. (NASDAQ:ECOR) 2021/07/12 21:48:50 Stock Equity
Inpixon (NASDAQ:INPX) with the stream of -3.21% also noticed, India electroCore, Inc. (NASDAQ:ECOR) encountered a rapid change of -2.65% in the last hour of Mondays trading session. Inpixon (NASDAQ:INPX) closed The post Hot Mover of the Day: Inpixon (NASDAQ:INPX), electroCore, Inc. (NASDAQ:ECOR) appeared first on Stocks Equity .